HYLG


Health Care Covered Call & Growth ETF

Reasons to Consider HYLG

High Income Potential

HYLG seeks to generate income by writing covered calls on the Health Care Select Sector SPDR Fund.

Upside Potential

By writing calls on 50% of the Health Care Select Sector SPDR Fund, the strategy allows investors to capture half the upside potential of the Health Care Select Sector Index.

Monthly Distributions

HYLG seeks to make distributions on a monthly basis.

Key Information As of 02/02/23

Inception Date 11/21/22
Gross Expense Ratio 0.66%
Net Expense Ratio* 0.60%
Net Assets $2.49 million
NAV $24.88
Fact Sheet

*Fee waivers are contractual and in effect until at least March 1, 2024.


ETF Summary

The Global X Health Care Covered Call & Growth ETF (HYLG) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Health Care Select Sector Index and the Health Care Select Sector SPDR Fund, and “writes” or “sells” corresponding call options on the Health Care Select Sector SPDR Fund representing approximately 50% of the value of HYLG’s portfolio.

ETF Objective

The Global X Health Care Covered Call & Growth ETF (HYLG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P Health Care Select Sector Half BuyWrite Index.

Trading Details As of 02/02/23

Ticker HYLG
Bloomberg Index Ticker BXLVH
CUSIP 37960A750
ISIN US37960A7506
Primary Exchange NYSE Arca
Shares Outstanding 100,000
Number of Holdings 66
30-Day Median Bid-Ask Spread 0.59%

Distributions As of 02/02/23

30-Day SEC Yield 1.15%
Unsubsidized 30-Day SEC Yield 1.09%
Distribution Frequency Monthly

ETF Prices As of 02/02/23

NAV $24.88 Daily Change -$0.08 -0.32%
Market Price $24.87 Daily Change -$0.09 -0.36%

Performance History

As of recent
(12/31/22)
Fund NAV Market Price Index
Year-to-Date -- -- --
1 Month -0.80% -0.64% -0.96%
3 Months -- -- 11.42%
Since Inception 1.42% 1.46% 1.41%
Year-to-Date -0.93% -1.21% -0.88%
1 Month -0.93% -1.21% -0.88%
3 Months -- -- 1.97%
Since Inception 0.48% 0.24% 0.52%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 02/02/23

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
55.20 XLV HEALTH CARE SELECT SECTOR 2371823 133.08 10,322 1,373,651.76
3.99 UNH UNITEDHEALTH GROUP INC 2917766 470.83 211 99,345.13
3.93 JNJ JOHNSON & JOHNSON 2475833 165.54 590 97,668.60
2.39 LLY ELI LILLY & CO 2516152 330.70 180 59,526.00
2.38 MRK MERCK & CO. INC. 2778844 103.46 572 59,179.12
2.32 ABBV ABBVIE INC B92SR70 144.84 399 57,791.16
2.26 PFE PFIZER INC 2684703 44.34 1,267 56,178.78
2.10 TMO THERMO FISHER 2886907 587.07 89 52,249.23
1.80 ABT ABBOTT LABORATORIES 2002305 112.25 399 44,787.75
1.63 DHR DANAHER CORP 2250870 270.68 150 40,602.00
1.42 BMY BRISTOL-MYERS SQUIBB CO 2126335 72.77 487 35,438.99
1.21 AMGN AMGEN INC 2023607 246.53 122 30,076.66
1.06 MDT MEDTRONIC PLC BTN1Y11 87.58 300 26,274.00
1.04 ELV ELEVANCE HEALTH INC BSPHGL4 480.41 54 25,942.14
1.03 CVS CVS HEALTH CORP 2577609 86.18 296 25,509.28
0.94 GILD GILEAD SCIENCES INC 2369174 81.39 287 23,358.93
0.86 SYK STRYKER CORP 2853688 282.48 76 21,468.48
0.85 CI CIGNA CORP BHJ0775 301.53 70 21,107.10
0.84 ISRG INTUITIVE SURGICAL INC 2871301 260.90 80 20,872.00
0.72 REGN REGENERON PHARMACEUTICALS 2730190 751.20 24 18,028.80
0.72 ZTS ZOETIS INC B95WG16 171.00 105 17,955.00
0.71 VRTX VERTEX PHARM 2931034 303.78 58 17,619.24
0.64 BDX BECTON DICKINSON AND CO 2087807 248.47 64 15,902.08
0.62 BSX BOSTON SCIENTIFIC CORP 2113434 48.07 320 15,382.40
0.57 HUM HUMANA INC 2445063 489.77 29 14,203.33
0.54 MRNA MODERNA INC BGSXTS3 176.35 76 13,402.60
0.50 HCA HCA HEALTHCARE INC B4MGBG6 257.99 48 12,383.52
0.48 EW EDWARDS LIFESCIENCES CORP 2567116 84.51 140 11,831.40
0.47 MCK MCKESSON CORP 2378534 366.48 32 11,727.36
0.42 A AGILENT TECHNOLOGIES INC 2520153 155.50 67 10,418.50
0.42 IQV IQVIA HOLDINGS INC BDR73G1 240.65 43 10,347.95
0.39 DXCM DEXCOM INC B0796X4 108.03 90 9,722.70
0.39 IDXX IDEXX LABORATORIES INC 2459202 504.22 19 9,580.18
0.38 BIIB BIOGEN INC 2455965 287.52 33 9,488.16
0.38 CNC CENTENE CORP 2807061 72.57 130 9,434.10
0.33 ILMN ILLUMINA INC 2613990 224.94 36 8,097.84
0.32 MTD METTLER-TOLEDO 2126249 1,583.88 5 7,919.40
0.30 RMD RESMED INC 2732903 226.61 33 7,478.13
0.26 ZBH ZIMMER BIOMET HO 2783815 127.41 50 6,370.50
0.25 ALGN ALIGN TECHNOLOGY INC 2679204 359.88 17 6,117.96
0.24 GEHC GE HEALTHCARE TECHNOLOGY BL6JPG8 70.65 83 5,863.95
0.23 ABC AMERISOURCEBERGEN CORP 2795393 158.47 36 5,704.92
0.21 BAX BAXTER INTERNATIONAL INC 2085102 47.01 110 5,171.10
0.21 LH LABORATORY CP 2586122 254.99 20 5,099.80
0.20 STE STERIS PLC BFY8C75 220.86 23 5,079.78
0.20 HOLX HOLOGIC INC 2433530 84.44 60 5,066.40
0.19 WST WEST PHARMACEUT 2950482 281.88 17 4,791.96
0.18 CAH CARDINAL HEALTH INC 2175672 76.28 60 4,576.80
0.18 WAT WATERS CORP 2937689 344.24 13 4,475.12
0.17 PKI PERKINELMER INC 2305844 144.38 30 4,331.40
0.16 MOH MOLINA HEALTHCARE INC 2212706 304.39 13 3,957.07
0.15 DGX QUEST DIAGNOSTICS INC 2702791 145.47 26 3,782.22
0.15 COO COOPER COS INC/THE 2222631 362.53 10 3,625.30
0.14 INCY INCYTE CORP 2471950 84.49 40 3,379.60
0.13 VTRS VIATRIS INC BMWS3X9 12.19 270 3,291.30
0.12 TECH BIO-TECHNE CORP BSHZ3Q0 80.85 36 2,910.60
0.11 HSIC HENRY SCHEIN INC 2416962 89.08 30 2,672.40
0.11 TFX TELEFLEX INC 2881407 262.22 10 2,622.20
0.10 CRL CHARLES RIVER LA 2604336 259.92 10 2,599.20
0.10 BIO BIO-RAD LABORATORIES-A 2098508 480.49 5 2,402.45
0.09 CTLT CATALENT INC BP96PQ4 56.64 40 2,265.60
0.09 UHS UNIVERSAL HLTH-B 2923785 150.43 15 2,256.45
0.08 XRAY DENTSPLY SIRONA INC BYNPPC6 39.66 50 1,983.00
0.07 OGN ORGANON & CO BLDC8J4 30.41 60 1,824.60
0.05 CASH 1.00 1,232 1,232.08
0.03 DVA DAVITA INC 2898087 85.82 10 858.20
-0.72 2XLV US 02/17/2023 C133 187.50 -95 -17,812.52
Holdings are subject to change. "Cash" denotes U.S. dollars.

ETF Research

Investing involves risk, including the possible loss of principal. Concentration in a particular industry or sector will subject HYLG to loss due to adverse occurrences that may affect that industry or sector. Investors in HYLG should be willing to accept a high degree of volatility in the price of the fund’s shares and the possibility of significant losses. The health care industry could be adversely affected by various political, regulatory, supply-and-demand, and other economic factors.

HYLG engages in options trading. An option is a contract sold by one party to another that gives the buyer the right, but not the obligation, to buy (call) or sell (put) a stock at an agreed upon price within a certain period or on a specific date. A covered call option involves holding a long position in a particular asset, in this case U.S. common equities, and writing a call option on that same asset with the goal of realizing additional income from the option premium. By selling covered call options, the fund limits its opportunity to profit from an increase in the price of the underlying index above the exercise price, but continues to bear the risk of a decline in the index. A liquid market may not exist for options held by the fund. While the fund receives premiums for writing the call options, the price it realizes from the exercise of an option could be substantially below the indices current market price. HYLG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. The market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share, and do not represent the returns you would receive if you traded shares at other times. NAVs are calculated using prices as of 4:00 PM Eastern Time. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Cboe, nor does Cboe make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Cboe.

Back to Top